Differential Network Analysis Integrates Pathway Mapping to Characterize Dynamic Metabolic Changes in the Progression of Diabetic Complications
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Wuping Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China. Hauptthemen laut MEDLINE: Metabolic Networks and Pathways, Metabolomics, Diabetes Complications, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Onset and progression of diseases are often characterized by dynamic changes in various metabolites. Monitoring these metabolic fluctuations is a central focus within the field of disease metabolomics. This study introduces an integrative analytical method that combines cross-comparative differential network analysis with network mapping to delineate the dynamic changes of diabetes rats in the fecal metabolome induced by a high-fat diet and streptozotocin. Our results indicate that the fecal metabolite networks are significantly associated with diabetes development. The network analysis identified 13 specific biomarkers linked to the progression of diabetic complications, highlighting that diabetes development is marked by an exacerbation of metabolic dysfunction. Interestingly, the networks analysis also uncovered age-related metabolites including BCAAs (leucine, isoleucine, valine), urocanate, tyrosine, lysine succinate, betaine, and cytosine, which may potentially promote the onset and progression of diabetes. Pathway analysis revealed disruptions in amino acid metabolism, ketone body synthesis and degradation, glycolysis/gluconeogenesis, galactose metabolism, nicotinamide metabolism, and purine metabolism, along with alterations in signaling pathways related to mineral absorption and neurotransmitter synaptic transmission. The cross-comparison network analysis in conjunction with network mapping analysis constitutes an effective method for exploring the dynamic metabolic networks implicated in diseases pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
- National Medical Metabolomics International Collaborative Research Center, Xiangya Hospital, Changsha 410008, China.
- Reproductive Medicine Center, The First Affiliated Hospital of China Naval Military Medical University, Shanghai 200433, China.
ORCID-Profile: Guiping Shen, Jianghua Feng
Förderung
- Natural Science Foundation of Hunan Province
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Huang, Y., Li, C., Song, G., Xiao, M., Shen, G., & Feng, J. (2025). Differential Network Analysis Integrates Pathway Mapping to Characterize Dynamic Metabolic Changes in the Progression of Diabetic Complications. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00021
Vancouver
Liu W, Huang Y, Li C, Song G, Xiao M, Shen G, et al. Differential Network Analysis Integrates Pathway Mapping to Characterize Dynamic Metabolic Changes in the Progression of Diabetic Complications. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00021
BibTeX
@article{Liu2025,
author = {Liu, Wuping and Huang, Yao and Li, Chanyi and Song, Ge and Xiao, Mengxiang and Shen, Guiping and Feng, Jianghua},
title = {Differential Network Analysis Integrates Pathway Mapping to Characterize Dynamic Metabolic Changes in the Progression of Diabetic Complications},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00021}
}
EUVIMED